Hexa-lactoside-triazanonane triacetic acid (nota) derivative, method for radiolabeling hexa-lactoside positron emission tomography (pet) imaging agent for liver receptor with ga-68, and hexa-lactoside pet imaging agent for liver receptor

US2019343971A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019343971-A1
Application numberUS-201816200833-A
CountryUS
Kind codeA1
Filing dateNov 27, 2018
Priority dateMay 9, 2018
Publication dateNov 14, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, a method for radiolabeling a hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor with Ga-68, and a hexa-lactoside PET imaging agent for a liver receptor. The hexa-lactoside-NOTA derivative is a conjugate of six chains of lactose with NOTA obtained by conjugating hexa-lactoside to a chelating agent p-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid in the presence of triethyl amine/dimethyl formamide as a solvent. The radiolabeling method comprises labeling with Ga-68 at room temperature. According to the present invention, the labeling effect is stable, the labeling efficiency of the labeled product is greater than 95%, the labeled product is highly stable and the radiochemical purity is still greater than 90% after 4 hours.

First claim

Opening claim text (preview).

What is claimed is: 1 . A hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, which is a conjugate of six chains of lactose with NOTA obtained by conjugating hexa-lactoside to a chelating agent p-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid (e.g. p-SCN-benzyl-NODA-GA) in the presence of triethyl amine/dimethyl formamide as a solvent. 2 . The hexa-lactoside-NOTA derivative according to claim 1 , wherein the hexa-lactoside is AHA-Asp[DCM-Lys(ah-Lac) 3 ] 2 . 3 . The hexa-lactoside-NOTA derivative according to claim 1 , wherein the NOTA is p-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid, p-SCN-benzyl-NODA-GA. 4 . A method for radiolabeling a hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor with Ga-68, comprising reacting 3-valent Ga-68 and a triazanonane triacetic acid (NOTA) conjugate of six chains of lactose with sodium acetate buffer in a freeze drying ampoule at room temperature. 5 . The radiolabeling method according to claim 4 , wherein the reaction at room temperature is continued for 15 min. 6 . The radiolabeling method according to claim 4 , wherein the reaction at room temperature takes place at pH 4-5. 7 . The radiolabeling method according to claim 4 , wherein the finish labeled product is hexa-lactoside-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid chelated with Ga-68. 8 . The radiolabeling method according to claim 4 , wherein the hexa-lactoside-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid in the labeled product is chelated with Ga-68 by 6 coordination bonds. 9 . A hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor, having a structure of: 10 . The imaging agent according to claim 9 , which is prepared by the steps of: reacting 3-valent Ga-68 and a triazanonane triacetic acid (NOTA) conjugate of six chains of lactose with sodium acetate buffer in a freeze drying ampoule at room temperature.

Assignees

Inventors

Classifications

  • attached to an oxygen atom of the saccharide radical · CPC title

  • Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids · CPC title

  • being a hydroxyalkyl group esterified by a fatty acid · CPC title

  • conjugates with a carrier being an organic compounds · CPC title

  • Isotopically modified compounds, e.g. labelled · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019343971A1 cover?
The present invention provides a hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, a method for radiolabeling a hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor with Ga-68, and a hexa-lactoside PET imaging agent for a liver receptor. The hexa-lactoside-NOTA derivative is a conjugate of six chains of lactose with NOTA obtained by conjugating hexa-l…
Who is the assignee on this patent?
Iner Aec Executive Yuan
What technology area does this patent fall under?
Primary CPC classification A61K51/0497. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).